Several recent studies discovered that non-invasive diagnostic approaches, such as magnetic resonance (MR)-based imaging (MRI) [43] and spectroscopy (MRS) [44] could be used to predict IDH mutations by measuring D-2-HG in gliomas with mM level sensitivity. This evidence concerns the gene IDH1 and glioma.